Abstract: The present invention provides a structure of a printed circuit board and a manufacturing method thereof. The method includes: (a) forming a circuit pattern on an insulating layer in which a seed layer is formed; (b) embedding the circuit pattern into the insulating layer by a press method; and (c) removing the seed layer. According to the present invention, a fine pattern may be formed without occurring alignment problem by forming a circuit pattern directly on an insulating layer and reliability of the formed fine pattern may be increased by performing a process of embedding protruded circuits into the insulating layer. In addition, possibility of inferior circuit occurring due to ion migration between adjacent circuits may be reduced by performing over-etching a circuit layer to be lower than a surface of the insulating layer during the etching process of removing a seed layer.

Abstract: A silane compound is represented by Formula 1: wherein each R1 is independently a single bond, an ether group, a carbonyl group, a thioether group, a sulfone group, or a substituted or unsubstituted C1 to C20 hydrocarbon group, R2 and R3 are each independently a substituted or unsubstituted C1 to C20 hydrocarbon group, each R4 is independently hydrogen or a C1 to C5 hydrocarbon group, each X is independently halogen, a hydroxyl group, C1 to C20 alkoxy, or C6 to C20 aryloxy, each Y is independently a single bond, an amide group, a thioester group, a hydroxyethylene group, a carbonyl group, an aromatic group or an ester group, a and b are each independently an integer from 1 to 3, a+b is 4, no is an integer from 0 to 5, n is an integer from 5 to 50, and p and q are each independently an integer from 0 to 4.

Abstract: The present invention relates to a beta-alanine derivative, pharmaceutically acceptable salts thereof, and a pharmaceutical composition including the same as an active ingredient. The novel beta-alanine derivative and pharmaceutically acceptable salts thereof according to the present invention may effectively inhibit the activity of DGAT1, which is an enzyme serving as a catalyst in the final step of the synthesis of neutral lipids, to thereby be effectively used as a pharmaceutical composition for preventing or treating various lipid metabolism-related disorders selected from the group consisting of obesity, dyslipidemia, fatty liver, insulin resistance syndrome, and hepatitis.

Abstract: The present invention relates to a fiducial marker comprising barium sulfate (BaSO4), a solvent, and a polyethylene glycol-poly(aminourethaneurea) multi-block copolymer, as active ingredients. The fiducial marker of the present invention has an effect of significantly remedying disadvantages of image distortion and dose distortion, which are involved in the gold inner marker used in the conventional art. The fiducial marker of the present invention has very limited in vivo mobility, and thus the fiducial marker is maintained at the position at which it has been initially injected. Since the fiducial marker of the present invention is maintained in a sol or liquid state before in vivo injection, and transited into a gel or solid phase after in vivo injection, the injectability of the fiducial marker by an injector syringe is favorable, and the state of the fiducial marker can be controlled into a phase suitable to each site of the therapeutic target.

Abstract: Disclosed herein are biomarkers useful for identifying and/or classifying bacterial infections in a subject.

Abstract: Disclosed is a laundry drying rack. The laundry drying rack in accordance with an embodiment of the present invention includes a plurality of fixing hangers disposed in parallel to each other on a drying rack frame on which laundry is hung, a plurality of oscillating links each performing a swing motion with respect to each fixing hanger as a pivot axis, a plurality of oscillating hangers each connected to a lower end of the oscillating link and shaking the laundry, hung on the fixing hanger, at the bottom of the corresponding fixing hanger, a driving unit generating power, and an electric unit providing the power generated by the driving unit as an oscillating force for the oscillating links.

Abstract: An embedded PCB, a multi-layer PCB using the embedded PCB, and a method of manufacturing the same are provided. The method of manufacturing an embedded PCB includes a first step of patterning an insulating layer on which a photoresist layer is formed using a laser such that parts of the insulating layer are selectively etched to form a circuit pattern region and a second step of filling the circuit pattern region with a plating material to form a circuit pattern. Accordingly, the method of manufacturing an embedded PCB can simultaneously or sequentially etch a photoresist layer and an insulating layer using a laser to form a circuit pattern so as to obtain a micro pattern and simplify a manufacturing process and achieve alignment accuracy in construction of a multi-layer PCB using the embedded PCB to thereby improve product reliability and yield.

Abstract: A thermoplastic resin composition includes a thermoplastic resin comprising a polycarbonate resin; inorganic fillers; and a sulfonate represented by Formula 1: wherein R1 is a C6 to C30 hydrocarbon group. The thermoplastic resin composition can have excellent impact resistance, rigidity, flame retardance, physical property balance therebetween, and the like.

Abstract: The present invention relates to a beta-alanine derivative, pharmaceutically acceptable salts thereof, and a pharmaceutical composition including the same as an active ingredient. The novel beta-alanine derivative and pharmaceutically acceptable salts thereof according to the present invention may effectively inhibit the activity of DGAT1, which is an enzyme serving as a catalyst in the final step of the synthesis of neutral lipids, to thereby be effectively used as a pharmaceutical composition for preventing or treating various lipid metabolism-related disorders selected from the group consisting of obesity, dyslipidemia, fatty liver, insulin resistance syndrome, and hepatitis.

Abstract: A hyper-branched polymer, which is a product obtained by performing condensation polymerization reaction of a hyper-branched polymer composition including a diisocyanate-based compound and a dihydroxyamine-based compound, a cross-linked hyper-branched polymer, an electrode and electrolyte membrane for a fuel cell including the hyper-branched polymer or the cross-linked hyper-branched polymer, and a fuel cell including the electrode and the electrolyte membrane.

Abstract: Methods are described for improving reproducibility of mass spectrum and quantitative analysis method using the same. More particularly, methods for improving reproducibility of a mass spectrum of a chemical compound, wherein temperatures of an ion generation reaction are controlled to be the same with each other, or wherein spectra of which temperature of ion generation reaction are the same with each other are selected from mass spectra of a chemical compound are described. In addition, methods for measuring an equilibrium constant of a proton transfer reaction between a matrix and an analyte at a certain temperature, for obtaining a calibration curve for quantitative analysis, and for quantitative analysis of an analyte by using mass spectra area described.

Abstract: Provided is a sulfamide derivative having an adamantyl group represented by the following Formula 1, or a pharmaceutically acceptable salt thereof. The sulfamide derivative suppresses the activity of 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD1), and is useful in the treatment of various diseases that are mediated by 11?-HSD1.

Abstract: A silane compound is represented by Formula 1: wherein each R1 is independently a single bond, an ether group, a carbonyl group, a thioether group, a sulfone group, or a substituted or unsubstituted C1 to C20 hydrocarbon group, R2 and R3 are each independently a substituted or unsubstituted C1 to C20 hydrocarbon group, each R4 is independently hydrogen or a C1 to C5 hydrocarbon group, each X is independently halogen, a hydroxyl group, C1 to C20 alkoxy, or C6 to C20 aryloxy, each Y is independently a single bond, an amide group, a thioester group, a hydroxyethylene group, a carbonyl group, an aromatic group or an ester group, a and b are each independently an integer from 1 to 3, a+b is 4, no is an integer from 0 to 5, n is an integer from 5 to 50, and p and q are each independently an integer from 0 to 4.

Abstract: The present invention relates to a method for diagnosing cancer using information on the aberrant glycosylation of a glycoprotein involved in cancer progress. More particularly, the present invention relates to a cancer diagnosis peptide marker which is screened by the steps of: separating a glycoprotein aberrantly glycosylated according to the occurrence and progress of cancer from the blood of a lung cancer patient by using lectin; and selecting a marker peptide produced by the hydrolysis of the glycoprotein isolated by lectin. The marker peptide can be effectively used as a cancer diagnosis marker and for the diagnosis of cancer.

Abstract: A method of transferring graphene includes depositing graphene on a side of at least one metal substrate to provide a metal substrate-graphene layer, stacking a target substrate on a side of the metal substrate-graphene layer to provide a stacked structure in which a side of the target substrate faces the graphene layer, and exposing the stacked structure to an electrolysis bath to remove the metal substrate and transfer the graphene onto the side of the target substrate.

Abstract: A polycarbonate resin composition includes: a polycarbonate resin; inorganic fillers including flake and acicular fillers; and a sulfonate represented by Formula 1, wherein the sulfonate is present in an amount of about 0.1 parts by weight to about 1.0 part by weight based on about 100 parts by weight of the polycarbonate resin. The polycarbonate resin composition can exhibit excellent stiffness, excellent impact resistance, excellent property balance therebetween, and the like. wherein R1 is a C6 to C30 hydrocarbon group; M is an alkali or alkali earth metal; and n is 1 or 2.